Additionally, GLP-1RAs protect against CVD by improving endothelial dysfunction, an early phase of atherosclerosis [28,29], triggered by high blood pressure, diabetes, and elevated cholesterol [30,31]
Weighing risks and benefits of liraglutideThe FDAs review of a new antidiabetic therapy
MariTide is one of the more scientifically interesting drugs in the obesity pipeline, because it does something backwards on purpose
Last modified November 12, 2018
The ideal candidate has undergone bariatric surgery at least one year prior, maintains a stable weight (even if higher than goal), demonstrates renewed appetite or eating behavior challenges, and has no contraindications like unresolved nutritional deficiencies
You do not need to worry about taking it with or without food, or avoiding water around the time you take your dose